The MLL recombinome of acute leukemias

Leukemia
Claus MeyerR Marschalek

Abstract

Chromosomal rearrangements of the human MLL gene are a hallmark for aggressive (high-risk) pediatric, adult and therapy-associated acute leukemias. These patients need to be identified in order to subject these patients to appropriate therapy regimen. A recently developed long-distance inverse PCR method was applied to genomic DNA isolated from individual acute leukemia patients in order to identify chromosomal rearrangements of the human MLL gene. We present data of the molecular characterization of 414 samples obtained from 272 pediatric and 142 adult leukemia patients. The precise localization of genomic breakpoints within the MLL gene and the involved translocation partner genes (TPGs) was determined and several new TPGs were identified. The combined data of our study and published data revealed a total of 87 different MLL rearrangements of which 51 TPGs are now characterized at the molecular level. Interestingly, the four most frequently found TPGs (AF4, AF9, ENL and AF10) encode nuclear proteins that are part of a protein network involved in histone H3K79 methylation. Thus, translocations of the MLL gene, by itself coding for a histone H3K4 methyltransferase, are presumably not randomly chosen, rather functionally selected.

References

Jun 21, 1994·Proceedings of the National Academy of Sciences of the United States of America·S A SchichmanC M Croce
Feb 26, 1998·Leukemia & Lymphoma·R MarschalekG H Fey
Aug 11, 2001·Science·T Jenuwein, C D Allis
Jun 18, 2002·Current Opinion in Cell Biology·Monika Lachner, Thomas Jenuwein
Oct 3, 2003·Cancer Cell·Mary Ellen MartinJay L Hess
Nov 7, 2003·Leukemia·F ErfurthP H Domer
Jan 1, 2005·Proceedings of the National Academy of Sciences of the United States of America·Claus MeyerRolf Marschalek
Apr 27, 2005·Cell·Yuki OkadaYi Zhang
May 4, 2005·Blood·Oliver TeuffelBeat W Schäfer

❮ Previous
Next ❯

Citations

Feb 16, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Shabnam ShalapourThomas Kammertoens
Jul 22, 2008·International Journal of Hematology·Tetsuya KurosuOsamu Miura
Nov 26, 2009·International Journal of Hematology·Shoichi KobayashiHeiwa Kanamori
Mar 6, 2009·Leukemia·C MeyerR Marschalek
May 1, 2013·Leukemia·C MeyerR Marschalek
Mar 16, 2007·Nature Reviews. Cancer·Felix MitelmanFredrik Mertens
Oct 25, 2007·Nature Reviews. Cancer·Andrei V Krivtsov, Scott A Armstrong
Dec 17, 2009·Nature Structural & Molecular Biology·Tomasz CierpickiJohn H Bushweller
Nov 19, 2010·The Journal of Biological Chemistry·Carolin BierRoland H Stauber
Sep 12, 2008·Annual Review of Pathology·Michael A Teitell, Pier Paolo Pandolfi
Oct 2, 2012·The Journal of Clinical Investigation·Charles G Mullighan
Dec 4, 2009·PLoS Biology·Dorothee MuellerRobert K Slany
Jul 1, 2011·Biological Chemistry·Nuno CerveiraManuel R Teixeira
Oct 27, 2009·Future Oncology·Christian Bach, Robert K Slany
Mar 19, 2014·Future Medicinal Chemistry·Tomasz Cierpicki, Jolanta Grembecka
Jan 7, 2009·Journal of Cancer Research and Clinical Oncology·Sebastian SchollKlaus Höffken
Jun 4, 2013·Leukemia & Lymphoma·Erika LaunayMarc-Antoine Belaud-Rotureau
Mar 2, 2013·Expert Opinion on Therapeutic Patents·Daniel B LipkaClarissa Gerhauser
Aug 12, 2014·Expert Review of Molecular Diagnostics·Meera Hameed
Nov 29, 2011·Clinics in Laboratory Medicine·Christine J Harrison
Dec 16, 2010·Cancer Genetics and Cytogenetics·Bella BieloraiAmos Toren
Apr 7, 2010·Cancer Genetics and Cytogenetics·Virginia M CóserMaria S Pombo-de-Oliveira

❮ Previous
Next ❯

Related Concepts